Vertebroplasty Needles Market Seen Reaching $1.95 Billion by 2030

The vertebroplasty needles market is projected to grow from $1.12 billion in 2025 to $1.95 billion by 2030, driven by spinal injuries, aging populations and higher healthcare spending. North America held the biggest regional share in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Vertebroplasty needles are tied to minimally invasive treatment for spinal compression fractures, a need that rises with osteoporosis, trauma and an aging population. - The market’s expected jump to $1.95 billion by 2030 signals continued demand for image-guided spinal procedures and precision surgical devices. - Growth in this category can affect hospitals, outpatient spine centers and medical device makers focused on fracture stabilization.

What happened: - The Business Research Company published a vertebroplasty needles market report covering market size, trends and a global forecast through 2035. - The report says the market will rise from $1.12 billion in 2025 to $1.26 billion in 2026. - The report projects a compound annual growth rate of 12.9% over the historical period and 11.6% through 2030. - The forecast puts the market at $1.95 billion by 2030. - The company posted the report on Sept. 2, 2026, from London. - A free sample is available here. - The full report is available here.

The details: - Vertebroplasty needles are used in vertebroplasty, a minimally invasive procedure that injects bone cement into a fractured vertebra under fluoroscopy or CT guidance. - The tools are designed to improve precision, reduce trauma to surrounding tissue and support cement delivery with minimal discomfort. - The report links market growth to more osteoporotic spinal fractures, broader acceptance of minimally invasive spinal procedures, a larger elderly population, wider access to fluoroscopy-guided interventions and expansion of spine care services in hospitals. - Forecast growth is also supported by outpatient spine surgery demand, advances in kyphoplasty, higher investment in precision surgical devices, aging trends worldwide and better cement delivery technology. - The report highlights wider adoption of single-use vertebroplasty needles, image-guided cement delivery systems, minimally invasive spinal treatments, more precise needle design and stronger focus on procedural safety. - The market has been supported by rising spine injuries, which include trauma or damage to the spinal cord, vertebrae or nearby tissue. - The Spinal Injuries Association said the UK recorded about 4,400 new spinal cord injury cases annually in May 2024, equal to one new paralysis case every two hours, with 105,000 total cases in 2024. - Rising healthcare spending is another demand driver. - Centers for Medicare & Medicaid Services data showed U.S. healthcare spending grew 7.5% in 2023 to $4.9 trillion, or about $14,570 per person. - The aging population is also expanding the addressable market for fracture-stabilization procedures. - UK government data showed 12.7 million people aged 65 or older in the UK in 2022, or 19% of the population. - That number is expected to rise to 22.1 million by 2072, equal to 27% of the population. - North America held the largest regional share in 2025. - Asia-Pacific is projected to be the fastest-growing region through the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America and the Middle East and Africa.

Between the lines: - The market’s growth story is less about a single breakthrough and more about converging demand drivers: more fractures, more older patients and more spending on less invasive care. - The emphasis on single-use and image-guided products suggests hospitals are prioritizing workflow, safety and procedural consistency. - Regional growth may shift toward Asia-Pacific as health systems expand access to spine care and medical device adoption broadens.

What's next: - The market is expected to keep climbing through 2030 if outpatient spine surgery and minimally invasive procedures continue gaining share. - Competitive focus will likely center on cement delivery accuracy, needle design and procedural safety. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated trend graphics.